Grupo en Enfermedades Infecciosas en Cáncer y Alteraciones Hematológicas, Universidad Nacional de Colombia, Bogotá, D.C., Colombia; Grupo de Infectología, Instituto Nacional de Cancerología E.S.E, Bogotá, D.C., Colombia.
Grupo en Enfermedades Infecciosas en Cáncer y Alteraciones Hematológicas, Universidad Nacional de Colombia, Bogotá, D.C., Colombia; Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia.
Biomedica. 2023 Aug 31;43(Sp. 1):32-40. doi: 10.7705/biomedica.6779.
Fungemia caused by Geotrichum spp. is rare and highly lethal. The Instituto Nacional de Cancerología in Bogotá reported just two cases: one in the period 2001-2007 and the other in 2012-2018. This type of infection is more common in any kind of immunocompromised patients, so it can occur in those with hematological malignancies. Here we present the case of a 27-year-old man, diagnosed with acute lymphoblastic leukemia in relapse and admitted with polyarthralgia for five days, febrile neutropenia, nonabscessed cellulitis, and bacteremia due to methicillin-sensitive Staphylococcus aureus. The patient received therapy with oxacillin and cefepime, but the febrile neutropenia persisted. A new set of blood cultures was taken, and antifungal treatment was started because of the suspicion of invasive fungal infection. Arthroconidia were identified in blood cultures and Geotrichum spp. was confirmed using matrix-assisted laser desorption-ionization mass spectrometry. The antifungal treatment was adjusted with amphotericin B deoxycholate for 14 days and voriconazole for four weeks, and after a prolonged stay, the patient was discharged. Although the incidence of fungemia caused by Geotrichum spp. is low, it must be considered in patients with hematological malignancies and persistent febrile neutropenia despite the broadspectrum antimicrobial treatment. The confirmation of fungemia causing agents, with proteomic tools such as the mentioned mass spectrometry, allows treatment adjustment and decreases complications, hospital stay, and mortality.
由根霉属引起的真菌血症较为罕见,且具有高度致死性。波哥大的国立癌症研究所报告了两例病例:一例发生在 2001-2007 年期间,另一例发生在 2012-2018 年期间。这种感染在任何类型的免疫功能低下的患者中更为常见,因此可能发生在患有血液恶性肿瘤的患者中。在这里,我们报告了一例 27 岁男性的病例,该患者被诊断患有复发的急性淋巴细胞白血病,并因五天的多发性关节痛、发热性中性粒细胞减少症、非脓肿性蜂窝织炎和耐甲氧西林金黄色葡萄球菌菌血症入院。患者接受了苯唑西林和头孢吡肟治疗,但发热性中性粒细胞减少症持续存在。由于怀疑存在侵袭性真菌感染,再次采集了一组血培养并开始进行抗真菌治疗。在血培养中发现了节孢子,并且使用基质辅助激光解吸电离质谱法确认了根霉属。抗真菌治疗调整为脱氧胆酸两性霉素 B 治疗 14 天和伏立康唑治疗四周,经过长时间的住院治疗后,患者出院。尽管由根霉属引起的真菌血症的发病率较低,但在血液恶性肿瘤患者中,即使广谱抗菌治疗后仍持续发热性中性粒细胞减少症,仍必须考虑这种疾病。使用根霉属等蛋白组学工具确认真菌血症病原体,可调整治疗并降低并发症、住院时间和死亡率。